- Home
- LFT vs XTNT Comparison
LFT vs XTNT Comparison
Compare LFT & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LFT | XTNT |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.1M | 68.9M |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | LFT | XTNT |
|---|---|---|
| Price | $1.14 | $0.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | ★ 110.5K | 108.6K |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | ★ 18.49% | N/A |
| EPS Growth | N/A | ★ 125.00 |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $53,337,000.00 |
| Revenue This Year | $668.15 | N/A |
| Revenue Next Year | N/A | $9.30 |
| P/E Ratio | ★ $13.49 | $17.19 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.12 | $0.44 |
| 52 Week High | $2.65 | $0.95 |
Technical Indicators
Market Signals| Indicator | LFT | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 30.83 | 41.45 |
| Support Level | N/A | $0.44 |
| Resistance Level | $1.40 | $0.68 |
| Average True Range (ATR) | 0.04 | 0.03 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 11.11 | 5.34 |
Price Performance
Historical ComparisonAbout LFT Lument Finance Trust Inc.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.